Skip to main content

Peer Review reports

From: Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab

Original Submission
8 Aug 2021 Submitted Original manuscript
11 Sep 2021 Reviewed Reviewer Report - Erkan Topkan
8 Oct 2021 Reviewed Reviewer Report
11 Oct 2021 Reviewed Reviewer Report
24 Dec 2021 Author responded Author comments - Julian Guggenberger
Resubmission - Version 2
24 Dec 2021 Submitted Manuscript version 2
2 Feb 2022 Reviewed Reviewer Report - Erkan Topkan
15 Feb 2022 Reviewed Reviewer Report
2 Mar 2022 Author responded Author comments - Julian Guggenberger
Resubmission - Version 3
2 Mar 2022 Submitted Manuscript version 3
7 Mar 2022 Author responded Author comments - Julian Guggenberger
Resubmission - Version 4
7 Mar 2022 Submitted Manuscript version 4
Publishing
9 Mar 2022 Editorially accepted
24 Mar 2022 Article published 10.1186/s12885-022-09395-6

You can find further information about peer review here.

Back to article page